Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography-Reference-Cited by-同舟云学术

Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography

Published:2017-11-03 Issue:1 Volume:104 Page:139-147
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Bauer Martin¹,Matsuda Akihiro¹,Wulkersdorfer Beatrix¹,Philippe Cécile²,Traxl Alexander³,Özvegy-Laczka Csilla⁴,Stanek Johann¹³,Nics Lukas²,Klebermass Eva-Maria²,Poschner Stefan⁵,Jäger Walter⁵,Patik Izabel⁴,Bakos Éva⁴,Szakács Gergely⁴⁶,Wadsak Wolfgang²⁷,Hacker Marcus²,Zeitlinger Markus¹,Langer Oliver¹²³

Affiliation:

1. Department of Clinical Pharmacology; Medical University of Vienna; Vienna Austria

2. Department of Biomedical Imaging und Image-guided Therapy, Division of Nuclear Medicine; Medical University of Vienna; Vienna Austria

3. Center for Health & Bioresources; AIT Austrian Institute of Technology GmbH; Seibersdorf Austria

4. Institute of Enzymology, Research Centre for Natural Sciences; Hungarian Academy of Sciences; Budapest Hungary

5. Department of Clinical Pharmacy and Diagnostics; University of Vienna; Vienna Austria

6. Institute of Cancer Research; Medical University of Vienna; Vienna Austria

7. Center for Biomarker Research in Medicine; CBmed GmbH; Graz Austria

Funder

Austrian Science Fund

Lower Austria Corporation for Research and Education (NFB)

National Research, Development and Innovation Office

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference37 articles.

1. Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs;Nies;Expert Opin. Drug Metab. Toxicol.,2008

2. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption;Shitara;Biopharm. Drug Dispos.,2013

3. Pharmacogenomics of human OATP transporters;König;Naunyn Schmiedebergs Arch. Pharmacol.,2006

4. Transporters and drug-drug interactions: important determinants of drug disposition and effects;König;Pharmacol. Rev.,2013

5. Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs;Maeda;Drug Metab. Pharmacokinet.,2008

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Humanization ofSLCO2B1in Rats Increases rCYP3A1 Protein Expression but Not the Metabolism of Erlotinib to OSI-420;Journal of Pharmacology and Experimental Therapeutics;2024-03-06

2. Simultaneous quantification of atorvastatin, erlotinib and OSI-420 in rat serum and liver microsomes using a novel liquid chromatography-mass spectrometry method;Journal of Pharmaceutical and Biomedical Analysis;2023-11

4. Uptake Transporters at the Blood–Brain Barrier and Their Role in Brain Drug Disposition;Pharmaceutics;2023-10-16

5. The fluorescence‐based competitive counterflow assay developed for organic anion transporting polypeptides 1A2, 1B1, 1B3 and 2B1 identifies pentamidine as a selective OATP1A2 substrate;The FASEB Journal;2023-10-02